TrialEuropean journal of cancer (Oxford, England : 1990)2024

Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials.

Xavier Choderlos de Laclos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.